TSX News -
Condor Announces 2024 Third Quarter Results
CALGARY, Alberta, Nov. 12, 2024 (GLOBE NEWSWIRE) — Condor Energies Inc. (“Condor” or the “Company”) (TSX:CDR), a Canadian based, internationally […]
CORRECTION—Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results
MALVERN, Pa., Nov. 12, 2024 (GLOBE NEWSWIRE) — In a release issued earlier today under the same headline by Neuronetics, Inc. (NASDAQ: […]
TSX News -
November 12, 2024 – Questerre reports third quarter 2024 results
THIS NEWS RELEASE IS NOT FOR DISSEMINATION OR DISTRIBUTION IN THE UNITED STATES OF AMERICA TO UNITED STATES NEWSWIRE SERVICES […]
Viridian Metals Announces Opening of Trading on TSX Venture Exchange on November 14, 2024
Not for distribution to U.S. news wire services or for dissemination in the United States VANCOUVER, British Columbia, Nov. 12, […]
Mirasol Resources Closes Private Placement Financing
VANCOUVER, British Columbia, Nov. 12, 2024 (GLOBE NEWSWIRE) — Mirasol Resources Ltd. (TSX-V: MRZ) (OTC: MRZLF) (the “Company” or “Mirasol”) […]
Home BancShares, Inc. to Participate in Fireside Chat at Stephens Annual Investment Conference – (Time Update)
CONWAY, Ark., Nov. 12, 2024 (GLOBE NEWSWIRE) — Home BancShares, Inc. (NYSE: HOMB) (“Home” or “the Company”), and its wholly-owned […]
UPDATE – embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results
PARSIPPANY, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) — Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a […]
Amethyst Health, a Partnership Between Black Star Wellness and AYR Wellness, Conditionally Awarded Vertically Integrated Medical License in New York
MIAMI, Nov. 12, 2024 (GLOBE NEWSWIRE) — AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (“AYR” or the “Company”), a leading […]
The Western Investment Company Files Information Circular and Provides Letter to Shareholders for Upcoming Annual General and Special Meeting
Scott Tannas, President and Chief Executive Officer, Thanks Shareholders for their Overwhelming Support to Shift Western from a Private Equity […]
Calidi Biotherapeutics Reports Third Quarter 2024 Operating and Financial Results
Announced FDA Clearance of the Northwestern University IND Application for NeuroNova (CLD-101) Clinical Trial in High-Grade Glioma. Presented data supporting […]
